- Home
- AQST vs LXFR Comparison
AQST vs LXFR Comparison
Compare AQST & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- LXFR
- Stock Information
- Founded
- AQST 2004
- LXFR 1898
- Country
- AQST United States
- LXFR United States
- Employees
- AQST N/A
- LXFR N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- LXFR Major Chemicals
- Sector
- AQST Health Care
- LXFR Industrials
- Exchange
- AQST Nasdaq
- LXFR Nasdaq
- Market Cap
- AQST 272.9M
- LXFR 314.6M
- IPO Year
- AQST 2018
- LXFR 2012
- Fundamental
- Price
- AQST $3.40
- LXFR $12.27
- Analyst Decision
- AQST Strong Buy
- LXFR
- Analyst Count
- AQST 6
- LXFR 0
- Target Price
- AQST $10.67
- LXFR N/A
- AVG Volume (30 Days)
- AQST 1.6M
- LXFR 116.6K
- Earning Date
- AQST 08-05-2025
- LXFR 07-29-2025
- Dividend Yield
- AQST N/A
- LXFR 4.22%
- EPS Growth
- AQST N/A
- LXFR 49063.50
- EPS
- AQST N/A
- LXFR 0.79
- Revenue
- AQST $54,228,000.00
- LXFR $399,500,000.00
- Revenue This Year
- AQST N/A
- LXFR $2.63
- Revenue Next Year
- AQST $45.71
- LXFR $3.30
- P/E Ratio
- AQST N/A
- LXFR $15.67
- Revenue Growth
- AQST 5.29
- LXFR 1.63
- 52 Week Low
- AQST $2.12
- LXFR $9.41
- 52 Week High
- AQST $5.80
- LXFR $15.64
- Technical
- Relative Strength Index (RSI)
- AQST 58.21
- LXFR 61.11
- Support Level
- AQST $3.13
- LXFR $11.16
- Resistance Level
- AQST $3.33
- LXFR $12.39
- Average True Range (ATR)
- AQST 0.21
- LXFR 0.32
- MACD
- AQST -0.03
- LXFR 0.05
- Stochastic Oscillator
- AQST 46.94
- LXFR 85.33
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.